Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pawitan

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|December 15, 1991
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST InvestigatorsT Akiyama, Y Pawitan, H Greenberg, et al.
British Journal of Cancer|July 27, 2013
Low-dose aspirin use and cancer characteristics: a population-based cohort studyF Jonsson, L Yin, C Lundholm, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 1, 1992
Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST)I Willund, L Gorkin, Y Pawitan, et al.
European Journal of Neurology|June 20, 2020
Blood biomarkers and prognosis of amyotrophic lateral sclerosisJ Sun, J J Carrero, U Zagai, et al.
Statistics in Medicine|October 12, 2011
Estimating the number of true discoveries in genome-wide association studiesWoojoo Lee, A Gusnanto, A Salim, et al.
The American Journal of Cardiology|October 1, 1991
Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST InvestigatorsP Denes, A M Gillis, Y Pawitan, et al.
Journal of the American College of Cardiology|October 1, 1993
Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experienceR W Peters, R G Zoble, P R Liebson, et al.
Oncogene|April 18, 2012
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancerA Ward, A Balwierz, J D Zhang, et al.
Circulation|January 1, 1995
Association between ease of suppression of ventricular arrhythmia and survivalS Goldstein, M M Brooks, R Ledingham, et al.
European Journal of Neurology|May 16, 2019
Antibiotics use and risk of amyotrophic lateral sclerosis in SwedenJ Sun, Y Zhan, D Mariosa, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|December 15, 1991
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST InvestigatorsT Akiyama, Y Pawitan, H Greenberg, et al.
British Journal of Cancer|July 27, 2013
Low-dose aspirin use and cancer characteristics: a population-based cohort studyF Jonsson, L Yin, C Lundholm, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 1, 1992
Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST)I Willund, L Gorkin, Y Pawitan, et al.
European Journal of Neurology|June 20, 2020
Blood biomarkers and prognosis of amyotrophic lateral sclerosisJ Sun, J J Carrero, U Zagai, et al.
Statistics in Medicine|October 12, 2011
Estimating the number of true discoveries in genome-wide association studiesWoojoo Lee, A Gusnanto, A Salim, et al.
The American Journal of Cardiology|October 1, 1991
Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST InvestigatorsP Denes, A M Gillis, Y Pawitan, et al.
Journal of the American College of Cardiology|October 1, 1993
Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experienceR W Peters, R G Zoble, P R Liebson, et al.
Oncogene|April 18, 2012
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancerA Ward, A Balwierz, J D Zhang, et al.
Circulation|January 1, 1995
Association between ease of suppression of ventricular arrhythmia and survivalS Goldstein, M M Brooks, R Ledingham, et al.
European Journal of Neurology|May 16, 2019
Antibiotics use and risk of amyotrophic lateral sclerosis in SwedenJ Sun, Y Zhan, D Mariosa, et al.
Pageof 3